Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Prednisone in Threatened Preterm Birth
NCT06103227Phase 3Completed
- Sponsor
- University of Mostar
- Start
- Nov 2023
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of prednisone in preterm birth, sponsored by University of Mostar. Started Nov 2023; status: completed.
02
Drugs
prednisone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT06103227.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06103227.